ST Premium
For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.
Ready to Win Big?
Try Now for Just $1!© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com
Aspire BioPharma, Inc. (ASBP) stock declined over -2,162.16%, trading at $0.58 on NASDAQ, down from the previous close of $0.74. The stock opened at $0.75, fluctuating between $0.53 and $0.75 in the recent session.
Aspire BioPharma, Inc. is a biotechnology company specializing in advanced diagnostic solutions and molecular testing. The company focuses on developing high-precision assays for disease detection, leveraging cutting-edge research in genetics and biochemistry to support healthcare and life sciences industries.
Employees | 2 |
Beta | 0.37 |
Sales or Revenue | N/A |
5Y Sales Change% | N/A |
Fiscal Year Ends | N/A |
Sector | Healthcare |
Industry | Biotechnology |